529
Views
10
CrossRef citations to date
0
Altmetric
Oncology

Evaluation of the performance of elastomeric pumps in practice: are we under-delivering on chemotherapy treatments?

ORCID Icon, , ORCID Icon, , , , , ORCID Icon, & ORCID Icon show all
Pages 2153-2159 | Received 08 Feb 2017, Accepted 30 Aug 2017, Published online: 30 Oct 2017
 

Abstract

Background and aims: Elastomeric pumps are widely used to facilitate ambulatory chemotherapy, and studies have shown that they are safe and well received by patients. Despite these advantages, their end of infusion time can fluctuate significantly. The aim of this research was to observe the performance of these pumps in real practice and to evaluate patients’ satisfaction.

Methods: This was a two-phase study conducted at three cancer units over 6 months. Phase-1 was an observational study recording the status of pumps at the scheduled disconnection time and noting remaining volume of infusion. Phase-2 was a survey of patients and their perception/satisfaction. Ethical approval was granted.

Results: A total of 92 cases were observed covering 50 cases disconnected at hospital and 42 disconnected at home. The infusion in 40% of hospital disconnection cases was slow, with patients arriving at hospital with unfinished pumps; 58% of these had an estimated remaining volume which exceeded 10 mL with 35% exceeded 20 mL. In 73% of these cases, and regardless of the remaining volume, the patient was disconnected and the pump was discarded.

Conclusions: The performance of pumps varied, which affected nurse workload and patients’ waiting-times. A smart system is an option to monitor the performance of pumps and to predict their accuracy.

Transparency

Declaration of funding

This manuscript was not funded.

Declaration of financial/other relationships

The authors would like to confirm that there is no conflict of interest. CMRO peer reviewers on this manuscript have no relevant financial or other relationships to disclose.

Ethical approval

Ethical approval to conduct both phases was sought and granted from the Clinical Audit committee at the Royal Marsden NHS Trust.

Acknowledgement

The authors would like to thank all the nurses and pharmacists at the MDU for all their help and support with this project.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.